Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Sun Pharma (Japan)
h-index: 7
Total citations: 656
Total papers: 50
Homepage:
https://jp.sunpharma.com/
Recent papers from Sun Pharma (Japan)
Effectiveness and tolerability of cephalexin and clavulanic acid fixed dose combination, amoxicillin and clavulanic acid fixed dose combination, and azithromycin in patients with pharyngitis in India: a real-world retrospective study from electronic medical records (PHARYSPOR)
Frontiers in Medicine · 2026
Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
Journal of Dermatological Treatment · 2026
Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on disease duration
European Psychiatry · 2025
Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on age
European Psychiatry · 2025
Impact of Lumateperone compared to Quetiapine on Quality of Life of Indian patients with Bipolar II depression: A post-hoc analysis of a Phase 3 study
European Psychiatry · 2025
Impact of Lumateperone compared to Quetiapine on MADRS in Indian patients with Bipolar II depression: A post-hoc analysis of a Phase 3 study
European Psychiatry · 2025
Correlation of MADRS and Q-LES-Q-SF in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study
European Psychiatry · 2025
Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on prior hypomanic episodes
European Psychiatry · 2025
Correlation of MADRS and YMRS in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study
European Psychiatry · 2025
Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on baseline BMI
European Psychiatry · 2025
Efficacy and Safety of Lumateperone compared to Quetiapine in Indian patients with Bipolar II depression: A subgroup analysis based on mixed symptoms
European Psychiatry · 2025
Correlation of Q-LES-Q-SF and YMRS in patients with Bipolar II depression: A post-hoc analysis of an Indian Phase 3 study
European Psychiatry · 2025
Medicinal plants in the treatment and prevention of respiratory diseases (review)
Гербариум. · 2025
Binding Kinetics, Bias, Receptor Internalization and Effects on Insulin Secretion in vitro and in vivo of a Novel GLP-1R/GIPR Dual Agonist, HISHS-2001
2025
A Constant Contact Community-Based Epidemiological Investigation (C3EI) for Malaria Elimination in Mandla District, Madhya Pradesh, India
2024
Formulation, Optimization, and Evaluation of Ezetimibe for Chronotherapeutic Drug Delivery using Compression-Coating Technology
International Journal For Multidisciplinary Research · 2024
#1782455 Study on Effectiveness in Real-world with Dapagliflozin and Sitagliptin Fixed dose combination in patients with Type 2 Diabetes Mellitus in India: Retrospective Study from Electronic Medical Records
Endocrine Practice · 2024
An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco
2024
Racial differences in familiarity, interest, and use of integrative medicine among patients with breast cancer
2024
An economic model to understand the cost-effectiveness of olanzapine orally dispersible tablets (ODT) and olanzapine film coated tablets as a group compared with other oral atypical antipsychotics for treating schizophrenia in Morocco
2023